Thomas Zindrick

Thomas Zindrick

Vorstandsvorsitzender bei GENELUX CORPORATION

Vermögen: 678 061 $ am 31.05.2024

65 Jahre
Health Technology
Consumer Services
Process Industries

Ursprung des Netzwerks ersten Grades von Thomas Zindrick

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 239
Public Company Pharmaceuticals: Major 25
7
Holding Company Biotechnology 7
Amitech Therapeutic Solutions, Inc
1
Private Company 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Thomas Zindrick

UnternehmenSektorVerknüpfte PersonenHauptposition
ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Dominique Monnet

David Hallal

Eric Grinstead

John Moriarty

James G. Stout

Joseph Newell

Mark Day

Sales & Marketing

Chief Executive Officer

General Counsel

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Director/Board Member

Investment Managers

David J. Scott

Anna Richo

J. Reason

Dennis Fenton

David W. Beier

James Daly

Michael Severino

General Counsel

Corporate Officer/Principal

Director/Board Member

Chief Operating Officer

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

University of California, Berkeley College/University

Terry Rosen

Jin Long Chen

Sean E. Harper

Joshua J. Ofman

Deepak Nath

Doctorate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Pharmaceuticals: Major

David J. Scott

Roger Perlmutter

Robert Bradway

David Reese

Timothy Powers

Director/Board Member

President

Director of Finance/CFO

President

Corporate Officer/Principal

College/University

Leonard Schaeffer

George A. Vandeman

Robert Bradway

Brian Kotzin

Mike Zahigian

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Undergraduate Degree

Undergraduate Degree

ELI LILLY AND COMPANY Pharmaceuticals: Major

Diana McKenzie

Richard Davies

Paul Eisenberg

Willard Dere

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Private Equity Investor

Corporate Officer/Principal

Pharmaceuticals: Major

David Hallal

Michael Narachi

Robert Bradway

Diana McKenzie

Director/Board Member

Director/Board Member

Director/Board Member

Corporate Officer/Principal

University of California, Davis College/University

Joseph Cappello

Michael Narachi

Willard Dere

Timothy Powers

Undergraduate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Biotechnology

David J. Scott

Brian M. McNamee

Robert Bradway

Sean E. Harper

Director/Board Member

Director/Board Member

Director/Board Member

Chief Executive Officer

College/University

Roger Perlmutter

Bradley J. Maroni

Paul Eisenberg

Catherine Stehman-Breen

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Graduate Degree

College/University

Brian M. McNamee

Stuart Tross

Anna Richo

Dung Thai

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Stuart Tross

Vance D. Coffman

James Tyree

Mark Day

Human Resources Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

KYTHERA BIOPHARMACEUTICALS INC Pharmaceuticals: Major

Dennis Fenton

John Smither

Majed Kheir

Susan Lundeen Smuck

Director/Board Member

Director of Finance/CFO

Corporate Officer/Principal

Human Resources Officer

Pharmaceuticals: Major

David J. Scott

Sean E. Harper

David Reese

Director/Board Member

Chief Executive Officer

Chief Executive Officer

ARCUS BIOSCIENCES, INC. Biotechnology

Terry Rosen

Kathryn Falberg

David W. Beier

Chief Executive Officer

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Roger Perlmutter

Sean E. Harper

Michael Severino

President

Corporate Officer/Principal

Director/Board Member

University of Utah College/University

Doug Samuelson

Nathan Hardy

Tony Yu

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Dennis Fenton

Michael Narachi

Michael Severino

Director/Board Member

Director/Board Member

Director/Board Member

MERCK & CO., INC. Pharmaceuticals: Major

George Morrow

Roger Perlmutter

Gregory L. Tewalt

Sales & Marketing

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

HOSPIRA, INC. Pharmaceuticals: Major

Dennis Fenton

Richard Davies

Andrew Knudten

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Dennis Fenton

James Tyree

Adrian Otte

Corporate Officer/Principal

Corporate Officer/Principal

President

Miscellaneous Commercial Services

Terry Rosen

David W. Beier

Joshua J. Ofman

Director/Board Member

Director/Board Member

Director/Board Member

SIENNA BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Dennis Fenton

John Smither

Majed Kheir

Director/Board Member

Director of Finance/CFO

Chief Operating Officer

University of Michigan College/University

Terry Rosen

Brian Lian

Sean B. W. Martin

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Kellogg School of Management College/University

Robert Eckert

Mary Mirabelli

Masters Business Admin

Graduate Degree

Medical Specialties

George Morrow

Kathryn Falberg

Director/Board Member

Director/Board Member

Biotechnology

Terry Rosen

David W. Beier

Director/Board Member

Director/Board Member

Medical/Nursing Services

John Moriarty

Craig Shepherd

Director/Board Member

Director/Board Member

COHERUS BIOSCIENCES, INC. Pharmaceuticals: Major

James Daly

Peter K. Watler

Director/Board Member

Chief Tech/Sci/R&D Officer

University of Cincinnati (Ohio) College/University

Joseph Cappello

James G. Stout

Doctorate Degree

Doctorate Degree

BIOASIS TECHNOLOGIES INC. Biotechnology

Mark Day

Dave Jenkins

Chief Executive Officer

Director of Finance/CFO

BIOMARIN PHARMACEUTICAL INC. Biotechnology

Kathryn Falberg

Willard Dere

Director/Board Member

Director/Board Member

College/University

George Morrow

Preston Klassen

Masters Business Admin

Graduate Degree

Indiana University College/University

James Tyree

Brian Lian

Masters Business Admin

Masters Business Admin

Agricultural Commodities/Milling

Anna Richo

Michael Kelly

Corporate Officer/Principal

Director of Finance/CFO

NEKTAR THERAPEUTICS Pharmaceuticals: Major

Urte Gayko

Brian Kotzin

General Counsel

Chief Tech/Sci/R&D Officer

Biotechnology

Preston Klassen

Paul Eisenberg

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Michael Kelly

Catherine Stehman-Breen

Director/Board Member

Chief Executive Officer

GARDINER HEALTHCARE ACQUISITIONS CORP. Financial Conglomerates

Marc F. Pelletier

Dave Jenkins

Chief Executive Officer

Director of Finance/CFO

University of Pittsburgh College/University

William Ashton

Dung Thai

Graduate Degree

Doctorate Degree

Medical Specialties

Deepak Nath

Mark Day

Corporate Officer/Principal

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Michael Kelly

David Hallal

Director of Finance/CFO

Sales & Marketing

Miscellaneous Commercial Services

Peter Longo

Marc F. Pelletier

Director/Board Member

Founder

The University of Chicago College/University

Timothy Powers

Catherine Stehman-Breen

Doctorate Degree

Doctorate Degree

Ruprecht-Karls-Universität Heidelberg College/University

Paul Scigalla

Andreas Grauer

Corporate Officer/Principal

Doctorate Degree

GE AEROSPACE Industrial Machinery

Brian M. McNamee

François de Carbonnel

Corporate Officer/Principal

Corporate Officer/Principal

National Taiwan University College/University

Wen-Tse Tseng

Jin Long Chen

Undergraduate Degree

Graduate Degree

Statistik

International

Vereinigte Staaten 48
Deutschland 2
Taiwan 2
Kanada 2

Sektoral

Health Technology 26
Consumer Services 16
Commercial Services 6
Finance 3
Health Services 2

Operativ

Director/Board Member 439
Corporate Officer/Principal 265
Independent Dir/Board Member 134
Undergraduate Degree 82
Chief Executive Officer 63
  1. Börse
  2. Insiders
  3. Thomas Zindrick
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT